IFNGR1 and myasthenia gravis: To elucidate the mechanism by which IFN‐γ signaling regulates the pathological progression of MG through BAFF secretion from neutrophils, we first established Ifngr1−/− bone marrow chimeric models by transplanting Ifngr1−/− donor bone marrow into wild‐type recipients (Figure 7C).